Manoalide structure
|
Common Name | Manoalide | ||
---|---|---|---|---|
CAS Number | 75088-80-1 | Molecular Weight | 416.550 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 609.6±55.0 °C at 760 mmHg | |
Molecular Formula | C25H36O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 203.3±25.0 °C |
Use of ManoalideManoalide is a potent Phospholipase A2 (PLA2) and Phospholipase C (PLC) inhibitor. Manoalide, a sesterpenoid compound, displays anti-inflammatory and antibacterial activities[1][2][3]. |
Name | manoalide |
---|---|
Synonym | More Synonyms |
Description | Manoalide is a potent Phospholipase A2 (PLA2) and Phospholipase C (PLC) inhibitor. Manoalide, a sesterpenoid compound, displays anti-inflammatory and antibacterial activities[1][2][3]. |
---|---|
Related Catalog | |
Target |
PLA2 PLC |
In Vitro | Manoalide (0.05 μM) impaires IL-7-induced entry of the B cell progenitors into S and G2/M phases and increases the population of apoptotic cells in IL-7-cultured B cell progenitors. In addition, Manoalide reduced IL-7-induced phosphorylation of S6 compared to the control without inhibitor pre-treatment[1]. |
In Vivo | Manoalide reverses venom preconditioning (VPC)-induced anti-inflammatory effects 24 h after surgical brain injury (SBI) in adult male Sprague-Dawley rats, 260 to 300 g[1]. |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 609.6±55.0 °C at 760 mmHg |
Molecular Formula | C25H36O5 |
Molecular Weight | 416.550 |
Flash Point | 203.3±25.0 °C |
Exact Mass | 416.256287 |
PSA | 75.99000 |
LogP | 5.19 |
Vapour Pressure | 0.0±4.0 mmHg at 25°C |
Index of Refraction | 1.549 |
Hazard Codes | Xn: Harmful; |
---|---|
Risk Phrases | 20/22 |
Safety Phrases | 36 |
Manoalide |
MFCD00153826 |
(5R)-5-Hydroxy-4-{(2R,6R)-6-hydroxy-5-[(3E)-4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-hexen-1-yl]-3,6-dihydro-2H-pyran-2-yl}-2(5H)-furanone |
2(5H)-Furanone, 4-[(2R,6R)-3,6-dihydro-6-hydroxy-5-[(3E)-4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-hexen-1-yl]-2H-pyran-2-yl]-5-hydroxy-, (5R)- |
(2R)-2-hydroxy-3-[(2R,6R)-6-hydroxy-5-[(E)-4-methyl-6-(2,6,6-trimethylcyclohexen-1-yl)hex-3-enyl]-3,6-dihydro-2H-pyran-2-yl]-2H-furan-5-one |